Complement in human disease: approved and up-and-coming therapeutics

EE West, T Woodruff, V Fremeaux-Bacchi, C Kemper - The Lancet, 2024 - thelancet.com
The complement system is recognised as a protector against blood-borne pathogens and a
controller of immune system and tissue homoeostasis. However, dysregulated complement …

Haemolytic uraemic syndrome

F Fakhouri, J Zuber, V Frémeaux-Bacchi, C Loirat - The Lancet, 2017 - thelancet.com
Haemolytic uraemic syndrome is a form of thrombotic microangiopathy affecting
predominantly the kidney and characterised by a triad of thrombocytopenia, mechanical …

Thrombotic microangiopathy and the kidney

V Brocklebank, KM Wood… - Clinical Journal of the …, 2018 - journals.lww.com
Thrombotic microangiopathy can manifest in a diverse range of diseases and is
characterized by thrombocytopenia, microangiopathic hemolytic anemia, and organ injury …

[HTML][HTML] Thrombophilia testing: a British Society for Haematology guideline

DJ Arachchillage, L Mackillop… - British journal of …, 2022 - ncbi.nlm.nih.gov
Guidelines Committee and the sounding board of BSH. It was also placed on the members
section of the BSH website for comment. It has also been reviewed by Royal College of …

Clinical practice guideline on pregnancy and renal disease

K Wiles, L Chappell, K Clark, L Elman, M Hall… - BMC nephrology, 2019 - Springer
Background Chronic kidney disease (CKD) is estimated to affect 3% of pregnant women in
high-income countries,(Piccoli et al., 2018,# 13860) which equates to between 15,000 …

Thrombotic microangiopathy in aHUS and beyond: clinical clues from complement genetics

F Fakhouri, V Frémeaux-Bacchi - Nature Reviews Nephrology, 2021 - nature.com
Studies of complement genetics have changed the landscape of thrombotic
microangiopathies (TMAs), particularly atypical haemolytic uraemic syndrome (aHUS) …

Management of thrombotic microangiopathy in pregnancy and postpartum: report from an international working group

F Fakhouri, M Scully, F Provôt, M Blasco… - Blood, The Journal …, 2020 - ashpublications.org
Pregnancy and postpartum are high-risk periods for different forms of thrombotic
microangiopathy (TMA). However, the management of pregnancy-associated TMA remains …

Thrombocytopenia in pregnancy

DB Cines, LD Levine - Hematology 2014, the American Society …, 2017 - ashpublications.org
Abstract Thrombocytopenia develops in 5% to 10% of women during pregnancy or in the
immediate postpartum period. A low platelet count is often an incidental feature, but it might …

Eculizumab in paroxysmal nocturnal haemoglobinuria and atypical haemolytic uraemic syndrome: 10‐year pharmacovigilance analysis

G Socié, MP Caby‐Tosi, JL Marantz… - British journal of …, 2019 - Wiley Online Library
Eculizumab is the first and only medication approved for paroxysmal nocturnal
haemoglobinuria (PNH) and atypical haemolytic uraemic syndrome (aHUS) treatment …

16th international congress on antiphospholipid antibodies task force report on antiphospholipid syndrome treatment trends

H Cohen, MJ Cuadrado, D Erkan, A Duarte-Garcia… - Lupus, 2020 - journals.sagepub.com
Antiphospholipid syndrome (APS), an acquired autoimmune thrombophilia, is characterised
by thrombosis and/or pregnancy morbidity in association with persistent antiphospholipid …